• No undisclosed information that could explain recent trading
• Cardiex confirms compliance with Listing Rules
• Responses authorized by Executive Chairman

Cardiex Ltd (ASX: CDX) has responded to an ASX price query regarding a recent increase in its share price from a low of $0.115 to a high of $0.155 on 17 February 2025. The company confirmed that it is not aware of any information concerning it that has not been announced to the market which, if known by some in the market, could explain the recent trading in its securities. Cardiex also confirmed that it is complying with the Listing Rules, particularly Listing Rule 3.1. The responses provided by Cardiex have been authorized and approved by the company's Executive Chairman. The ASX had requested Cardiex to respond to several questions, including whether the company was aware of any information about its earnings for the 6-month period ended 31 December 2024 that could differ materially from any guidance provided or surprise the market. Cardiex stated that it is not aware of any such information. The company also confirmed that it is not relying on Listing Rule 3.1A to withhold any information from the market.